Welcome to nudaPETides. Coming soon.

The prescribing platform for veterinary peptide medicine. For licensed veterinarians.

Formulary
Blend. Dermatologic.Dog. CatTier C

GLOW

The signature dermal and coat blend. GHK-Cu plus BPC-157 plus TB-500. Skin regeneration protocol.

Components

GHK-Cu + BPC-157 + TB-500

Combined studies

53 referenced

Type

Combination protocol

Full monograph, dosing tables, and prescribing rationale are available to verified veterinarians with an active license and documented VCPR workflow. Request access to unlock the complete formulary library. Request access.

Overview

GLOW is the integumentary regeneration protocol. Three peptides targeting the skin and coat from three angles. GHK-Cu drives collagen and elastin synthesis in fibroblasts. BPC-157 drives angiogenesis and re-epithelialization at wound margins. TB-500 drives cell migration and endothelial repair.

The result is what prescribers describe as the glow effect. Coat quality. Skin turgor. Scar remodeling. Chronic dermatologic improvement.

Mechanism of action

  1. 01GHK-Cu activates over 4,000 genes tied to dermal repair and remodeling.
  2. 02BPC-157 accelerates re-epithelialization at wound and inflammation sites.
  3. 03TB-500 drives cell migration and cytoskeletal remodeling in dermal fibroblasts.
  4. 04Combined action addresses collagen synthesis, vascularization, and cell migration in one protocol.
  5. 05Delivered topically or as low-dose local injection at the treatment site.

Molecular data

ComponentDetail
GHK-CuCopper tripeptide
BPC-157Pentadecapeptide
TB-500Thymosin beta-4 fragment
RouteTopical or low-dose local injection

Species applicability

Dog

Chronic atopic dermatitis. Post-surgical scar remodeling. Coat quality in aging dogs. Chronic hot spots refractory to conventional therapy.

Cat

Chronic dermatologic conditions. Post-surgical dermal recovery. Copper contraindications require careful selection.

Prescribing indications

DermatologicEFFECTIVE

Chronic dermatologic conditions.

RecoveryEFFECTIVE

Post-surgical wound and scar support.

AestheticEMERGING

Coat quality and skin quality in senior animals.

Dosing framework

Full monograph, dosing tables, and prescribing rationale are available to verified veterinarians with an active license and documented VCPR workflow. Request access to unlock the complete formulary library.

Request access

Reconstitution and administration

Full monograph, dosing tables, and prescribing rationale are available to verified veterinarians with an active license and documented VCPR workflow. Request access to unlock the complete formulary library.

Request access

What to expect

Week 1 to 2Reduced dermal inflammation at treated sites.
Week 2 to 4Improved re-epithelialization and skin comfort.
Week 4 to 8Coat quality and skin turgor improvements.

Research library

See individual monographs for GHK-Cu, BPC-157, and TB-500. Combination protocol evidence rests on the additive mechanisms.GHK-CuBPC-157 monograph and evidence library.BPC-157TB-500 monograph and evidence library.TB-500

Related peptides

GHK-Cu

Dermatologic

View

BPC-157

Recovery

View

Wolverine

Blend. Recovery.

View

Dispensed only as a patient-specific compounded prescription under FDA GFI 256.

Regulatory footing

This monograph describes a compounded veterinary medication available by prescription only through a licensed veterinarian inside an active veterinarian-client-patient relationship. Not FDA-approved for animal or human use. Compounded on a patient-specific basis under FDA Guidance for Industry #256. For educational use by licensed veterinarians. Not intended for consumer self-prescribing.

For licensed veterinarians only. Compounded under FDA GFI 256. Not FDA-approved.